TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/19/2025ACC: 0001712276-25-000011
Officer· Chief Financial Officer
Since Feb 2026
-11.91K
Net shares
Net seller
$49.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.91K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−11.91K
Price / share
$4.14
Trade value
$49.30K
% of position
1.5%
11/17/2025
804.17K→792.26K
Total
Net shares
−11.91K
Net value
-$49.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/17/2025 | F · Tax Withholding | −11.91K | $4.14 | $49.30K | 1.5% | 804.17K | 792.26K |
| Total | −11.91K | -$49.30K | ||||||
Derivative Transactions0
No derivative transactions reported